Partnerships

The RCSB Protein Data Bank, headquartered at the Rutgers Institute for Quantitative Biomedicine, announced the expansion of its data storage capacity through the Amazon Web Services (AWS) Open Data Sponsorship Program. The AWS program is providing the Protein Data Bank with more than 100 terabytes of storage for no-cost delivery of information to millions of scientists, educators, and students around the world who are working in fundamental biology, biomedicine, bioenergy, bioengineering and biotechnology.

Rutgers University and Tel Aviv University (TAU) signed a memorandum of understanding that will further the collaboration between the two research universities and establish a presence by TAU at The Hub, a 550,000-square-foot, $665 million project in New Brunswick, NJ.

A group of Camden barbers has now taken on the role of community ambassadors for the safety and importance of the COVID-19 vaccine, thanks to an innovative new awareness campaign led by Rutgers University–Camden and the Center For Family Services in Camden.

Leading experts at Rutgers and Tel Aviv Universities hosted a symposium centered on the coronavirus pandemic and the research, response and lessons learned through the COVID-19 outbreak in the sister states of New Jersey and Israel. 

A novel base editing technology invented at Rutgers, with the potential to be used for the creation of new cell and gene therapies, will be made available to researchers worldwide through an exclusive partnership with the Horizon Discovery Group.

Rutgers University signs two agreements with Santhera Pharmaceuticals to advance pioneering research for the treatment of congenital muscular dystrophy. The agreements complement ongoing research of Peter Yurchenco, professor at Rutgers Robert Wood Johnson Medical School and a pioneer in a novel gene therapy approach for the treatment of LAMA2-deficient congenital muscular dystrophy.